
Blueberry Vinegar Boosts Memory in Lab
NUTRITION: Blueberry vinegar may fight dementia by improving cognitive function. Learn about improvements to short-term memory in the lab as reported in The Journal of

NUTRITION: Blueberry vinegar may fight dementia by improving cognitive function. Learn about improvements to short-term memory in the lab as reported in The Journal of

REVIEW VIDEO: Wife of country music legend Glen Campbell shares her message of hope regarding her family’s personal journey with Alzheimer’s.

VIDEO + ARTICLE: Phase II/III trials are begining in the Tau NextGen study. The study will assess the effect of Lecanemab, an experimental anti-amyloid therapy,

DEMENTIA DESIGN & FREE BOOK: Improve the independence of people with dementia. This online book is available at no charge. Learn dozens of clever design

The majority of nursing homes in California have not reached full compliance with a statewide COVID-19 vaccine mandate for staff at long-term care facilities, and

An experimental drug, NAP, has been found to remedy slow development, poor communication and brain issues similar to those found in Alzheimer’s patients. Find out

BREAKTHROUGH: The US Food and Drug Administration (FDA) has granted a “Breakthrough Therapy” designation for donanemab, a potential new treatment for people with early symptomatic

BREAKTHROUGH & TREATMENT: The new Alzheimer’s drug aducanumabab (Aduhelm) has received accelerated approval by the US Food and Drug Administration. Why did it take so

DIAGNOSIS: The PrecivityAD™ blood test accurately and reliably detected brain amyloid on a single blood sample. Intended for people with memory and thinking issues, the

WEBINAR: You are cordially invited to a conversation with Dr. David Holtzman about his PrecivityAD groundbreaking new blood test to aid in the diagnosis of

Three major GLP-1 trials came out in late 2025. One weight-loss drug slowed early Alzheimer’s decline, while two others failed. Surprisingly, this mixed pattern may point the way toward a promising new treatment direction.

New long-term data suggests lecanemab could delay the shift from mild memory loss to moderate Alzheimer’s by up to eight years—offering families precious time and renewed hope.

Strengthening social connections may offer a surprising boost to long-term brain health.

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.


